Clinical Trials · NCT06369610
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Mayo Clinic
- Enrollment
- 110
- Start date
- Apr 2024
- Locations
- 1 site, United States
- Primary endpoint
- Hormonal domain scores